Dr Thangarajan Rajkumar, Director of Research Oncology at MedGenome, highlights genetic mutations in cancer. Germline and somatic mutations influence diagnosis and treatment. Next-generation sequencing (NGS) helps identify hereditary risks and targeted therapies, improving outcomes. Early screening, lifestyle changes, and precision medicine enhance cancer prevention and treatment strategies.